PubRank

Bastian Schilling

Author PubWeight™ 17.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res 2013 1.84
2 Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods 2012 1.46
3 Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells. Clin Cancer Res 2013 1.43
4 Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients. Eur J Immunol 2012 1.21
5 Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets. J Immunol Methods 2011 1.15
6 Induced and natural regulatory T cells in human cancer. Expert Opin Biol Ther 2012 1.15
7 Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity. J Clin Oncol 2013 1.14
8 Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their management. Semin Oncol 2010 1.02
9 Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer. Clin Cancer Res 2013 0.98
10 TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One 2013 0.95
11 Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophils. J Immunol 2013 0.93
12 Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker. Am J Surg Pathol 2016 0.90
13 Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patients. Pediatr Res 2013 0.87
14 Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. J Transl Med 2014 0.80
15 Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med 2014 0.79
16 Conjunctival melanomas harbor BRAF and NRAS mutations--response. Clin Cancer Res 2013 0.77
17 Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature 2016 0.75
18 Oncogene Status of an Interdigitating Dendritic Cell Sarcoma: Recurrent Mutations in NF1, TP53, and ARID2 Shared With Melanoma. Am J Surg Pathol 2016 0.75
19 Liebe Leserinnen und Leser. J Dtsch Dermatol Ges 2016 0.75
20 Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab. Acta Derm Venereol 2017 0.75